PDD vs RNAZ · P/E 8.4, rev $61.75B vs $5.1M cap
PDD Holdings Inc. (PDD) versus Transcode Therapeutics Inc (RNAZ) — a side-by-side from cached financials, not a winner call.
PDD Holdings Inc. (PDD) is a internet retail company listed on NASDAQ.
Transcode Therapeutics Inc (RNAZ) is a biotechnology company listed on NASDAQ.
Latest reported PDD revenue for 2025-12-31 was $61.75B. Net income was $13.99B. Revenue was up 14.5% from 2024-12-31 to 2025-12-31. PDD currently screens at market cap $113.67B and trailing P/E 8.4.
RNAZ does not have a complete income-statement cache yet.
PDD currently screens at market cap $113.67B and trailing P/E 8.4. RNAZ currently screens at market cap $5.1M.
Not investment advice. Open the PDD and RNAZ stock pages for the full models.
Not investment advice.